Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn (Retracted article. See vol. 102, pg. 141, 2010)
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn (Retracted article. See vol. 102, pg. 141, 2010)
复制标题
DOI:
10.1016/j.lungcan.2009.06.013
复制
发表时间:
2010-02-01
期刊:
影响因子:
5.3
通讯作者:
Wang, En-Hua
中科院分区:
文献类型:
--
作者:
Dai, Shun-Dong;Wang, Yan;Wang, En-Hua
Background: Kaiso is a recently identified transcription factor that binds to p120-catenin (p120ctn), an Armadillo catenin and cell adhesion cofactor. However, clinical studies of human solid tumors have not been reported to investigate relationship between these proteins.Methods: Expression and localization of Kaiso and p120ctn were examined in 196 lung cancer specimens (including 55 cases of paired lymph node metastases and 80 cases with complete follow-up records) by immunohistochemistry. Three lung cancer cell lines, BE1, SPC, and A549 were used to establish p120ctn stably ablated or overexpressed cell lines. Co-immunoprecipitation was used to confirm p120ctn bind Kaiso in lung cancer tissue and cell lines. Localization and expression levels of Kaiso were detected via immunofluorescence, cytoplasmic vs. nuclear fractionation Western blot analysis and reverse transcription-polymerase chain reaction.Results: Cytoplasmic Kaiso expression was evident in 115 (58.7%), and abnormal p120ctn expression was noted in 168 (85.7%). Cytoplasmic Kaiso and abnormal p120ctn expressions were associated with higher degree of malignancy (high-stage and lymph node metastases, all P